Company page

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is a public company traded under the ticker OCUL in the American market. The company has a market capitalization of approximately $1.86 billion. Ocular Therapeutix focuses on developing and commercializing innovative therapies for eye diseases and conditions.

OCUL:NASDAQUpdated August 28, 2026
Ocular Therapeutix, Inc. logo
Ticker
OCUL:NASDAQ
Asset type
Stock
Market cap
$2.28B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD